Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Li Ran

Showing results (221-230 of 224) with videos related to

Pageof 23
Sort By:
You have reached the last page of results.This site can display upto 224 results.
The New Phytologist|March 1, 2020
Sclerenchyma cell thickening through enhanced lignification induced by OsMYB30 prevents fungal penetration of rice leavesWeitao Li, Kang Wang, Mawsheng Chern, et al.
Cell|July 1, 2017
A Natural Allele of a Transcription Factor in Rice Confers Broad-Spectrum Blast ResistanceWeitao Li, Ziwei Zhu, Mawsheng Chern, et al.
BMC Cancer|December 18, 2019
Vaginal dose of radical radiotherapy for cervical cancer in China: a multicenter studyJuan Wang, Kai-Shuo Zhang, Tao Wang, et al.
Therapeutic Advances in Medical Oncology|November 4, 2022
A prospective, open-label, multicenter phase IV clinical trial on the safety and efficacy of lobaplatin-based chemotherapy in advanced breast cancerMin Yan, Peng Yuan, Quchang Ouyang, et al.
Pageof 23

Showing results (221-230 of 224) with videos related to

Sort By:
Pageof 23
You have reached the last page of results.This site can display upto 224 results.
The New Phytologist|March 1, 2020
Sclerenchyma cell thickening through enhanced lignification induced by OsMYB30 prevents fungal penetration of rice leavesWeitao Li, Kang Wang, Mawsheng Chern, et al.
Cell|July 1, 2017
A Natural Allele of a Transcription Factor in Rice Confers Broad-Spectrum Blast ResistanceWeitao Li, Ziwei Zhu, Mawsheng Chern, et al.
BMC Cancer|December 18, 2019
Vaginal dose of radical radiotherapy for cervical cancer in China: a multicenter studyJuan Wang, Kai-Shuo Zhang, Tao Wang, et al.
Therapeutic Advances in Medical Oncology|November 4, 2022
A prospective, open-label, multicenter phase IV clinical trial on the safety and efficacy of lobaplatin-based chemotherapy in advanced breast cancerMin Yan, Peng Yuan, Quchang Ouyang, et al.
Pageof 23